Published Date: 10 Mar 2023
China: A recent study by BMC Medicine has shown that the amount of insoluble fiber from various foods plays an important role...
Read Full NewsImmune checkpoint inhibitors have been FDA-approved for head and neck cancer for a decade, but their use has only marginally increased among patients younger than 65.
As the first chemotherapy-free regimen to beat gemcitabine/cisplatin, perioperative enfortumab vedotin plus pembrolizumab could shift muscle-invasive bladder cancer care — but questions remain.
Belzutifan plus lenvatinib significantly improves outcomes vs single agent cabozantinib in patients with advanced RCC who progressed after anti-PD-(L)1 therapy, new data show.
1.
Alkem introduces cetuximab under the trade name Cetuxa in India.
2.
When BCG is not effective in treating bladder cancer, Oncolytic Virus exhibits high response rates.
3.
FDA-approved FGFR inhibitors show promise against rare and aggressive pediatric brain tumor
4.
Nearly 4 million lung cancer deaths averted and 76 million years of life gained due to tobacco control in US
5.
Antitumor mRNA-based vaccines show potential against gastric cancer metastasis
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
3.
New Research on Craniopharyngioma
4.
Nuclear Medicine's Role in Battling Women's Cancers
5.
Lu-177 Vipivotide in Prostate Cancer: A Breakthrough in Radioligand Therapy
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
2.
Efficient Management of First line ALK-rearranged NSCLC
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation